Clinical study of daunomycin and prednisone for induction of remission in children with advanced leukemia.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001856:Bone Marrow Examination; D002481:Cellulitis / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D003630:Daunorubicin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D007970:Leukopenia / Q000139:chemically induced; D011241:Prednisone / Q000008:administration & dosage* / Q000009:adverse effects; D013280:Stomatitis / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors
D000970:Antineoplastic Agents; D011241:Prednisone; D003630:Daunorubicin